Evidence map›Paper›PMID 42506594›Full record

ArticleVaccines2026

Measles Surveillance in Tuscany (Italy), 2019-2024: A Six-Year Epidemiological Analysis.

Manuela Chiavarini, Rossella Romano, Andrea Guida, Elena Morelli, Camillo Di Nizio, Teresa Vladina Picchi, Giulia Napoli, Roberta Murolo, Vittorio Filieri, Barbara Rita Porchia and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Manuela ChiavariniDepartment of Health Sciences, University of Florence, 50134 Florence, Italy.ORCID 0000-0002-3551-7486
Rossella RomanoSchool of Specialization in Hygiene and Preventive Medicine, Department of Health Sciences, University of Florence, 50134 Florence, Italy.
Andrea GuidaSchool of Specialization in Hygiene and Preventive Medicine, Department of Health Sciences, University of Florence, 50134 Florence, Italy.ORCID 0000-0002-1278-7053
Elena MorelliSchool of Specialization in Hygiene and Preventive Medicine, Department of Health Sciences, University of Florence, 50134 Florence, Italy.
Camillo Di NizioSchool of Specialization in Hygiene and Preventive Medicine, Department of Health Sciences, University of Florence, 50134 Florence, Italy.
Teresa Vladina PicchiSchool of Specialization in Hygiene and Preventive Medicine, Department of Health Sciences, University of Florence, 50134 Florence, Italy.
Giulia NapoliSchool of Specialization in Hygiene and Preventive Medicine, Department of Health Sciences, University of Florence, 50134 Florence, Italy.ORCID 0009-0007-1784-8373
Roberta MuroloSchool of Specialization in Hygiene and Preventive Medicine, Department of Health Sciences, University of Florence, 50134 Florence, Italy.
Vittorio FilieriSchool of Specialization in Hygiene and Preventive Medicine, Department of Health Sciences, University of Florence, 50134 Florence, Italy.
Barbara Rita PorchiaRegione Toscana, Direzione Sanità, Welfare e Coesione Sociale, 50127 Florence, Italy.
Daniela SenatoreRegione Toscana, Direzione Sanità, Welfare e Coesione Sociale, 50127 Florence, Italy.
Giovanna BiancoRegione Toscana, Direzione Sanità, Welfare e Coesione Sociale, 50127 Florence, Italy.
Paolo BonanniDepartment of Health Sciences, University of Florence, 50134 Florence, Italy.ORCID 0000-0003-2875-3744
Sara BoccaliniDepartment of Health Sciences, University of Florence, 50134 Florence, Italy.ORCID 0000-0002-9695-7549
Angela BechiniDepartment of Health Sciences, University of Florence, 50134 Florence, Italy.ORCID 0000-0002-6013-8779

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDespite sustained public-health efforts, measles continues to re-emerge in Europe. According to the ECDC, 1045 measles cases were reported in Italy in 2024. We describe epidemiological trends and characteristics of measles cases in the Tuscany Region from 2019 to 2024.

methodsWe conducted a population-based retrospective study using cases reported through the national surveillance system (PREMAL). Incidence rates were calculated using demographic data from the Italian National Institute of Statistics (ISTAT). Cases were stratified by year, sex, age group, vaccination status (2024), and hospital admission; temporal, demographic, and clinical trends were analysed.

resultsFrom 2019 to 2024, 204 cases were reported, corresponding to a mean annual incidence of 0.93 per 100,000 population (95% CI: 0.80-1.07) and a cumulative incidence of 5.58 per 100,000 (95% CI: 4.78-6.31). Females accounted for 63.2% of cases (

conclusionsThe 2024 measles resurgence in Tuscany mainly affected unvaccinated adults. These findings highlight persistent immunity gaps among adults, suggesting that protection and prevention measures are also needed in the population (0-4 y).

Indexed as

adultschildrenepidemicepidemiologyimmunizationmeaslesMorbillivirus Infectionsoutbreakpublic health preparednessvaccination

Identifiers

PMID42506594
PMCPMC13417429

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.